AIA Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$435K Sell
7,707
-6,423
-45% -$375K 0.01% 303
2025
Q4
$840K Buy
14,130
+10,033
+245% +$546K 0.01% 272
2025
Q3
$222K Buy
4,097
+377
+10% +$21.6K ﹤0.01% 393
2025
Q2
$204K Buy
3,720
+595
+19% +$35K ﹤0.01% 326
2025
Q1
$221K Sell
3,125
-580
-16% -$39K 0.01% 309
2024
Q4
$244K Buy
3,705
+270
+8% +$18.1K 0.01% 280
2024
Q3
$241K Buy
3,435
+458
+15% +$38.3K 0.01% 281
2024
Q2
$245K Sell
2,977
-1,099
-27% -$91.5K 0.01% 274
2024
Q1
$356K Buy
4,076
+266
+7% +$23.8K 0.01% 259
2023
Q4
$367K Sell
3,810
-563
-13% -$49.8K 0.02% 250
2023
Q3
$387K Sell
4,373
-370
-8% -$32.9K 0.02% 235
2023
Q2
$411K Sell
4,743
-4,767
-50% -$449K 0.02% 265
2023
Q1
$925K Buy
9,510
+5,197
+120% +$539K 0.05% 162
2022
Q4
$446K Buy
4,313
+2,707
+169% +$254K 0.03% 237
2022
Q3
$136K Sell
1,606
-1,106
-41% -$98.5K 0.01% 340
2022
Q2
$225K Buy
+2,712
New +$216K 0.01% 344

Other funds holding BMRN